Using tumor purity–corrected RNA-seq data from TCGA (Pancan21 dataset, n = 8290 tumors), we found a strong negative relationship between median MYCN expression and median IFN type I signature within cancer types with high MYCN expression (Fig. 7E). The gene discussed is MYCN; the disease is neoplasm.